Biogen’s New Boss Is Delivering, but Stock Isn’t Pricing It in Yet
Wall Street Journal
The decision to buy Reata signals a new era under CEO Chris Viehbacher, and Wall Street’s skepticism presents an opportunity.
Understanding current events through the lenses of the past and future.
Wall Street Journal
The decision to buy Reata signals a new era under CEO Chris Viehbacher, and Wall Street’s skepticism presents an opportunity.